Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have been given an average rating of “Hold” by the seven ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company.

Several research firms have commented on SAUHY. Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Monday, December 15th. The Goldman Sachs Group lowered shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft raised Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. UBS Group raised Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Finally, Citigroup restated a “sell” rating on shares of Straumann in a report on Wednesday, October 22nd.

Straumann Price Performance

OTCMKTS SAUHY opened at $11.73 on Friday. The firm has a 50-day moving average price of $11.85 and a 200 day moving average price of $12.02. Straumann has a 52-week low of $10.30 and a 52-week high of $15.07.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.